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The herpesvirus entry mediator A (HVEM/HveA) and nectin-1 (HveC/CD111) are two major receptors for herpes simplex virus (HSV).
Although structurally unrelated, both receptors can independently mediate entry of wild-type (wt) HSV-1 and HSV-2 by interacting with the
viral envelope glycoprotein D (gD). Laboratory strains with defined mutations in gD (e.g. rid1) do not use HVEM but use nectin-2 (HveB/
CD112) for entry. The relative usage of HVEM and nectin-1 during HSV infection in vivo is not known. In the absence of a defined in vivo
model, we used in vitro approaches to address this question. First, we screened HSV clinical isolates from various origins for receptor tropism
and found that all used both HVEM and nectin-1. Second, we determined the numbers of surface receptors on various susceptible and
resistant cell lines as well as on primary fibroblasts derived from an individual with cleft lip/palate ectodermal dysplasia (CLPED1).
Although CLPED1 cells can only express a defective form of nectin-1, they allowed entry of wild type and mutant HSV strains by usage of
either HVEM or nectin-2. Finally, we compared the ability of HVEM and nectin-1 to mediate entry when expressed at varying cell surface
densities. Both receptors showed a direct relationship between the number of receptors and HSV susceptibility. Direct comparison of
receptors suggests that nectin-1 is more efficient at promoting entry than HVEM. Overall, our data suggest that both receptors play a role
during HSV infection in vivo and that both are highly efficient even at low levels of expression.
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Introduction tion and secondary reactivation, mucosae are the main sitesHerpes simplex virus (HSV) is a human pathogen caus-
ing orolabial infections (mainly HSV type 1) or sexually
transmitted genital infections (mainly type 2) (Whitley,
2001). HSVestablishes a lifelong latent infection punctuated
by episodes of reactivation leading to a productive lytic
infection (Roizman and Knipe, 2001). During initial infec-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Center, New York, NY 10029.for HSV replication whereas sensory neurons are latently
infected reservoirs. Secondary lesions are usually benign
and contained by the host immune response. However,
HSV-1 complications such as encephalitis, eye infection,
or skin dissemination can happen especially in immuno-
compromised hosts. Neonatal infection is also a severe
complication of HSV-2 infection at birth. During in vivo
HSV infection, cell tropism is limited but targets involve
various cell types such as neurons and epithelial cells
(Whitley, 2001). However, in vitro, most human and animal
cell lines are susceptible to HSV infection.
HSV entry into mammalian cells requires the presence
of a specific cell surface receptor able to bind envelope
glycoprotein D (gD) and trigger the mechanism leading to
membrane fusion (Campadelli-Fiume et al., 2000; Spear et
al., 2000). Several structurally unrelated receptors for wild-
C. Krummenacher et al. / Virology 322 (2004) 286–299 287type (wt) HSV-1 and 2 have been identified: herpesvirus
entry mediator A (HVEM/HveA) is a member of the tumor
necrosis factor receptor (TNFR) family (Montgomery et
al., 1996) whereas nectin-1 (HveC) belongs to the immu-
noglobulin (Ig) superfamily (Cocchi et al., 1998b; Ger-
aghty et al., 1998; Lopez et al., 1995). In addition, a form
of heparan sulfate modified by 3-OST3 can also bind to
gD and permit HSV-1 entry (Shukla et al., 1999). Nectin-2
is a weak receptor for HSV-2 and not a receptor for wt
HSV-1 (Lopez et al., 2000; Martinez and Spear, 2001;
Warner et al., 1998). However, HSV-1 strains selected to
overcome gD-mediated interference (Dean et al., 1994)
were able to use nectin-2 but were unable to bind and use
HVEM as a receptor (Geraghty et al., 1998; Krumme-
nacher et al., 1998; Montgomery et al., 1996; Whitbeck et
al., 1997). These viral strains harbor point mutations in the
N-terminal part of gD: Q27P for Rid1, Q27R for rid2,
L25P, Q27R with T230I for ANG (Dean et al., 1994;
Kaerner et al., 1983). Although these mutants use nectin-2,
a direct interaction between soluble nectin-2 and gD was
not evident probably because of low affinity (Lopez et al.,
2000; Warner et al., 1998). In contrast, the interaction of
gD with HVEM and nectin-1 in vitro was extensively
characterized. Both receptors have the same affinity for
soluble gD KOS (Krummenacher et al., 1998, 1999; Rux
et al., 1998; Willis et al., 1998). Consistent with the
functional data, gD rid1 did not bind HVEM but bound
nectin-1 with a 10-fold higher affinity (Krummenacher et
al., 1998, 1999; Willis et al., 1998). The binding site for
HVEM on gD is accurately known from X-ray crystallo-
graphic studies and mutagenesis (Carfı´ et al., 2001; Con-
nolly et al., 2002, 2003), whereas it is not clear how the
structurally unrelated nectin-1 interacts with gD. Studies
using mutagenesis and antibodies to block entry support
the idea that both binding sites overlap or are closely
located but clearly different (Carfı´ et al., 2001; Krumme-
nacher et al., 1998; Milne et al., 2003; Nicola et al., 1998;
Whitbeck et al., 1999). So far, no HSV strains have been
described that have lost the ability to use nectin-1 and rely
on alternate receptors for survival in cell culture.
HVEM mRNA was detected in many tissues rich in
lymphoid cells (Hsu et al., 1997; Kwon et al., 1997;
Montgomery et al., 1996). HVEM is present on primary T
cells, B cells, NK cells, monocytes, and dendritic cells
(Harrop et al., 1998; Kwon et al., 1997; Salio et al.,
1999). In addition, HVEM was directly detected in gingival
tissue on epithelial cells, fibroblasts, and endothelial cells
(Hung et al., 2002). Nectin-1 mRNA is expressed in
multiple tissues (Cocchi et al., 1998b; Geraghty et al.,
1998; Lopez et al., 1995). Many cell lines express nectin-
1 mRNA (Cocchi et al., 1998a; Geraghty et al., 1998; Lopez
et al., 1995), however, the level of surface expression varies
from cell line to cell line (Huber et al., 2001; Krummenacher
et al., 2000) and no quantitative data are available. Most
relevant for HSV pathogenesis is the expression of nectin-1
in the skin (Matsushima et al., 2003) in neuronal tissues(Cocchi et al., 1998b; Richart et al., 2003) or neuronal cell
lines (Geraghty et al., 1998; Krummenacher et al., 2000).
Also relevant is the expression of nectin-1 in the eye (Haarr
et al., 2001) and in keratinocytes of oral origin (Hung et al.,
2002). Nectin-1 mRNA was detected in teeth buds, olfac-
tory, and skin epithelia of mouse embryos (Suzuki et al.,
2000). Moreover, nectin-1 protein was detected in adult
mouse vagina (Shukla et al., 2000) and on neurons in rat and
mouse brains (Mata et al., 2001; Mizoguchi et al., 2002;
Richart et al., 2003).
Nectin-1 is a cell adhesion molecule located at adherens
junctions where it trans-interacts with itself or other nectins
(Krummenacher et al., 2002; Reymond et al., 2000; Satoh-
Horikawa et al., 2000; Tachibana et al., 2000; Takahashi et
al., 1999; Takai and Nakanishi, 2003). Nectin-1 is highly
conserved between species (Milne et al., 2001; Shukla et al.,
2000) and shows a limited allelic variability in human
populations (So¨zen et al., 2001; Struyf et al., 2002). In
humans, nonsense mutations in the nectin-1 gene were
linked to the cleft lip/palate ectodermal dysplasia syndrome
(CLPED1) also known as ectodermal dysplasia type 4
(ED4) or Margarita Island ED (So¨zen et al., 2001; Suzuki
et al., 2000). CLPED1 is characterized by cleft lip/palate,
syndactylia, and hidrotic ectodermal dysplasia. Such symp-
toms suggest that nectin-1 plays a role during embryogen-
esis in limbs and craniofacial development (Suzuki et al.,
2000).
The expression data of these molecules tend to suggest
that nectin-1 is a more relevant receptor because it is found
on cells targeted by HSV in vivo. However, there are no
compelling data to conclude that one receptor is more
critical than the other for HSV infection and spread in vivo.
The lack of a suitable animal model displaying a defined
receptor pattern and the ability of the available HSV strains
to use multiple receptors are two impediments preventing an
answer to the crucial question of which receptor is actually
used during HSV pathogenesis. In an attempt to address this
question and circumvent these problems, we used alternate
approaches in vitro. (i) We tested the receptor tropism of
HSV clinical isolates and found that all retained the ability
to use HVEM and nectin-1 regardless of type or origin. This
suggests that both receptors might be required in vivo. (ii)
We measured the number of each receptor on cell lines
relevant for HSV studies and showed that many cells
express low levels of surface HVEM and nectin-1. (iii)
We found that wild type and rid1 HSV have redundant
possibilities to enter fibroblasts and that CLPED1 fibro-
blasts are infected via either HVEM or nectin-2, respective-
ly. (iv) We compared the efficiency of HVEM and nectin-1
molecules to allow virus entry when expressed at limiting
cell surface density. Our data indicate that levels of entry
correlate with numbers of receptors expressed and that both
receptors efficiently promote virus entry even below limits
of quantification. However, results suggest that each mole-
cule of nectin-1 is more efficient at promoting entry com-
pared to HVEM.
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Receptor usage by HSV clinical isolates from various
anatomical origins
We first analyzed the receptor tropism of a collection of
clinical isolates and a panel of laboratory strains. The
anatomical sources of isolates reflect various pathologic
conditions commonly associated with HSV infections.
These viruses were derived from oral and genital lesions
as well as from disseminated neonatal infection or enceph-
alitis. Isolates obtained from various laboratories (Table 1)
were amplified once on Vero cells and titered on these same
cells. Virus typing was verified by screening lysates of cells
infected with many type-specific antibodies against gD and
gC (data not shown). Parallel cultures of CHOK1-derived
cell lines were infected using approximately the same
multiplicity of infection. CHOK1 cells are naturally resistant
to wt HSV infection due to the lack of a functional receptor
(Shieh et al., 1992). Each cell line expresses a single HSV
receptor: CHO-M1A cells express HVEM, CHO-M2A
express nectin-2, and CHO-M3A express nectin-1 (data
not shown and Krummenacher et al., 1999). Upon HSV
infection, these cells, as well as the control cells CHO-IEh8Table 1
Origins of HSV strains and clinical isolates
Origin Namea Type Laboratory
Oral LC 1 Cohen/Eisenberg
VT7581, VT242,
VT4688, VT53, VT5227,
VT0006948R, VT7644,
VT7632, VT5968,
VT6064, VT6225,
VT1736RVT6866,
VT002723R, VT3557
1 Hodinka
VT2190 2 Hodinka
Vaginal VT4362, VT5053,
VT0005186R, VT5305,
VT55489, VT5627,
VT0000592U
2 Hodinka
VT4775, VT4912 1 Hodinka
212 2 Friedman
Genital I, II, III, V 1 Lakeman
A, B, C, D 2 Lakeman
Neonatal 1, 3, 4, 5, 9 2 Lakeman
2, 6, 7, 8 1 Lakeman
CNS H129, H1193, H166Rd-CSF,
H168Rd, H144, H150
1 Dix
Lab. strains KOS, ANG/KOS, Rid1 1 Spear
ANG 1 Kaerner
Rodanus PP, Rodanus regular,
CGA-3, MacIntyre, KOS(low),
KOS(high), 17Syn+, McRae,
F, RE
1 Hill
McMahon, Boyer, Ournomes,
E377, M6H10
1 Pereira
HF, 186 1 Cohen/Eisenberg
a Denominations for laboratory strains and clinical isolates are as specified
by the donating scientists.(no receptor) express h-galactosidase under the control of
the ICP4 viral promoter (Montgomery et al., 1996).
All HSV lab strains and clinical isolates were able to
enter M3A cells expressing nectin-1, although the level of
infectivity of each strain and isolate varied (Fig. 1). In
addition, all clinical isolates entered M1A cells expressing
HVEM. As controls, laboratory strains with defined gD
mutations at residues 25 or 27 (i.e. rid1, ANG, HF) (Dean et
al., 1994; Kaerner et al., 1983; Lingen et al., 1995) were
unable to use HVEM as a receptor. As expected, these same
strains were able to efficiently use nectin-2 to enter cells
(Fig. 1). Among clinical isolates, viruses from oral and
neonatal origin did not use nectin-2. In contrast, several but
not all genital isolates, mainly type 2, used nectin-2.
Interestingly, nectin-2 usage was prevalent among HSV-1
isolates derived from patients with HSV encephalitis. The
same CNS isolates also gave higher signals in parental
CHO-IEh8 cells. This most likely reflects the ability of
these strains to use an undetermined HSV receptor present
on CHO cells (Shieh et al., 1992).
None of the clinical isolates displayed the tropism of the
gD mutant lab strains rid1 and ANG which fail to use
HVEM but use nectin-2. To confirm the absence of a rid1-
like phenotype among the clinical isolates which could use
nectin-2, we attempted to block infection with soluble
gD(306t) derived from HSV-1 KOS (Sisk et al., 1994). This
form of gD had a lower affinity for nectin-1 compared to the
homolog construct from HSV-1 rid1 (Krummenacher et al.,
1999) and therefore was unable to block entry of HSV rid1
and ANG while it efficiently blocked HSV-1 KOS entry into
mammalian cells (A. Nicola, G. Cohen, R. Eisenberg.
unpublished data). Entry of these clinical isolates could be
blocked by gD(306t), thus, confirming that none had a rid1-
like phenotype (data not shown).
Taken together, these data indicate that all of the primary
isolates were able to use both HVEM and nectin-1. More-
over, several genital isolates of HSV-2 appeared to use
nectin-2 and some CNS isolates of HSV-1 were able to
utilize nectin-2 as well as an undefined receptor present on
CHO cells.
Distribution and quantification of receptors on cell lines by
QFACS
Although cell tropism of HSV in vivo appears limited,
most cultured cell lines are susceptible to wild-type HSV
infection. Even the few mutant viruses unable to use HVEM
but still using nectin-1 and nectin-2 (e.g. rid1) can enter
most cultured cell lines. One possible interpretation is that
nectin-1 is the predominant receptor or preferred receptor on
most cell lines. However, there are no data that compare the
numbers of receptors expressed on cell lines, which could
explain their level of susceptibility to HSV. Here, we set out
to quantify the number of HVEM and nectin-1 molecules
present on various cell types commonly used to study HSV
infection.
Fig. 1. Entry of HSV strains and clinical isolates into CHO cells expressing defined human receptors. CHO-M1A expressing human HVEM, CHO-M2A
expressing human nectin-2, CHO-M3A expressing human nectin-1, and untransfected CHO-IEh8 (CHO) cells were infected. Cells were incubated with virus
for 1 h at 4 jC and then infection proceeded at 37 jC for 6 h. Activity of h-galactosidase expressed in infected cells was quantified as a measure of virus entry.
Solid bars represent type 1 viruses, hatched bars represent type 2 viruses.
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average number of each receptor per cell (Lee et al., 1999b).
This assay allowed us to determine the actual number of
antibody (Ab) binding sites (ABS) for a given Ab. Anti-receptor MAbs were first tested for their ability to saturate
cell surface of highly positive cells (C10 and A10). Anti-
HVEM MAb CW10 (Bender et al., 2003) and anti-nectin-1
MAb CK41 (Krummenacher et al., 2000) satisfied this
Fig. 2. Quantification of anti-receptors antibodies binding sites on cell lines.
(A) Transfected cell lines derived from murine melanoma B78H1 cells.
Numbers of antibodies binding sites (ABS) per cell for anti-HVEM CW10
and anti-nectin-1 CK41 are represented. (B) CK41 ABS on transfected cells
derived from CHO-K1 cells expressing nectin-1 (M3A), HVEM (M1A), or
no receptor (CHO-IEh8). (C) CW10 ABS on human and simian cell lines.
(D) CK41 ABS on human and simian cells lines. CK6 data (hatched bars)
are only shown for qualitative comparison because CK6 is used below
saturation levels and might not represent total numbers of ABS. Cell lines
labeled with a star are functionally (B78, B78H1, CHO) or genetically
(FED4 and LED4) deficient in expressing the tested receptors and serve as
negative controls. Data represent the average of three independent
experiments. Error bars indicate F1 SD.
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shown), and were selected for quantification experiments.
CK41 detects an epitope that overlaps the gD-binding site of
nectin-1; therefore, this antibody accurately quantifies the
available functional receptor on cell surface. None of the
available anti-HVEM MAbs with epitopes in the gD-bind-
ing site of HVEM (Whitbeck et al., 2001) could be used
because they did not saturate the cell surface. However, the
CW10 epitope does not overlap the active domain of the
receptor but detects HVEM in a saturable fashion. Initially,
we set up conditions using a panel of stable cell lines
derived from B78H1 cells using CW10 and CK41 directly
coupled to phycoerythrin (Fig. 2A). B78H1 cells do not
express HSV receptors and only become susceptible to
infection when transfected to express HVEM (A10, B78-
A), nectin-1 (C10), or nectin-1-GFP (CXG10, CG23), but
not when transfected with empty vector (B78) (Connolly et
al., 2003; Krummenacher et al., 2002, 2003; Miller et al.,
2001; Milne et al., 2003). Low background staining was
observed on receptor negative B78H1, B78, or CHO-IEh8
(Figs. 2B, D). High numbers of HVEM molecules were
expressed on the two independent cell lines A10 (48  103
ABS/cell) and B78-A (77  103 ABS/cell). An even larger
number of nectin-1 molecules were detected on C10 cells
(360  103 ABS/cell). Nectin-1, as a GFP fusion protein,
was also highly expressed on CXG10 (310  103 ABS/cell)
and CG23 cells (176  103 ABS/cell) (Krummenacher et
al., 2003) (Fig. 2A).
In contrast to the highly expressing transfected C10 cells,
transfected CHO-M3A cells (Krummenacher et al., 2000)
expressed lower numbers of nectin-1 (20  103 ABS/cell)
(Fig. 2B) in a range similar to levels observed on untrans-
fected human cell lines (e.g. IMR5, A431, Hela) (Fig. 2D).
Staining of negative B78H1 cells is indicative of back-
ground (Figs. 2A, C, D); however, the lower quantification
limit can vary from cell type to cell type (Figs. 2C, D). For
instance, FED4 fibroblasts genetically unable to express
membrane-anchored nectin-1 displayed a higher back-
ground of CK41 staining than the genetically similar
LED4 lymphoblasts (Fig. 2D). Therefore, due to variability
of background, data in Figs. 2C and D represent maximum
numbers of ABS present on these cells.
By screening standard cell lines we found variations in
the numbers of ABS per cell for both receptors (Figs. 2C,
D). The variation of receptor density within a cell popula-
tion, mainly for HVEM, varied significantly as indicated by
the large standard deviations. HVEM was detected at low
levels (less than 12  103 ABS/cell) in most cell lines but
was below reliable levels of quantification by QFACS in
SY5Y and 293T cells using MAb CW10 (Fig. 2C). Al-
though Vero cells appear positive, it is possible that CW10
detects HVEM on Vero cells and human cell lines with a
different efficiency.
Nectin-1 expression was quite variable but remained
below 28  103 ABS/cell (A431 cells). On neuroblastoma
cell lines, nectin-1 was predominant in SY5Y (27  103
Fig. 3. Entry of HSV-1 into human primary fibroblasts. Monolayers of
CLPED1-derived fibroblasts (FED4) (A) and normal fibroblasts (B) were
infected with wild-type HSV-1 KOS tk12 or mutant HSV-1 rid1 tk12 at
various MOI. Both viruses encode the LacZ reporter gene. Entry was
measured as h-galactosidase activity 6 h post infection.
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levels in IMR5 (Fig. 2D). In the case of nectin-1 we also
used a second MAb (CK6 coupled to APC) for detection.
This antibody detects a linear epitope and provides an
additional way of detecting nectin-1, which might adopt
alternate conformations on cell surfaces. CK6-APC anti-
body did not saturate the C10 cell surface in this assay (data
not shown), therefore the numbers of nectin-1 epitopes
detected by this antibody are shown solely for qualitative
comparison with CK41 (Fig. 2D). When nectin-1 was
detected on the surface of human cells, numbers of CK6
ABS were consistently lower than numbers of CK41 ABS.
However, both CK6 and CK41 seemed to have similar
background levels on FED4 and LED4 cell lines. Interest-
ingly, Vero cells showed a higher number of CK6 ABS than
of CK41 ABS. Although the staining of Vero cells with
CK6 was similar to the staining of the human cells SY5Y
and A431, the detection of simian nectin-1 by CK41 was
around background level. This can be explained by a
different conformation of simian nectin-1, which affects
the conformation-dependent epitope of CK41 whereas the
linear epitope recognized by CK6 is conserved (Milne et al.,
2003).
In conclusion, several cell lines express both HVEM and
nectin-1, albeit at low levels. It is likely that most cell lines
offer redundant possibilities for wild-type HSV to enter.
Infection of human primary fibroblasts carrying a mutated
gene for nectin-1
The use of human primary cells genetically restricted in
the expression of one of the main receptors for studies of
HSV entry combines two important advantages. First, such
cells are an excellent alternative to the more artificial system
of transfected mammalian cells. Second, these cells offer
clues, albeit indirect, to the susceptibility of individuals with
limited receptor availability to HSV infection. A well-
characterized example is the nonfunctional HIV co-receptor
CCR5D32. Homozygous carriers of this mutation show a
resistance to HIV infection and a slower progression to-
wards AIDS (Liu et al., 1996).
In human a few HVEM and nectin-1 alleles display point
mutations yet encode functional HSV receptors (Struyf et
al., 2002). Mutations introducing stop codons before the
membrane anchoring region of nectin-1 are linked to the
cleft lip/palate ectodermal dysplasia syndrome (CLPED1)
(So¨zen et al., 2001; Suzuki et al., 2000). It is not known if
the few individuals with CLPED1 are susceptible to HSV.
Primary fibroblasts (FED4) and lymphoblasts (LED4) de-
rived from affected individuals were used for infection
studies in vitro.
We compared the susceptibility of FED4 and normal
matched fibroblasts to infection by wt HSV-1 KOS and
mutant HSV-1 rid1. Interestingly, FED4 cells were efficient-
ly infected by both viruses (Fig. 3A). Matched normal
fibroblasts (Fig. 3B) and fetal lung fibroblasts (FLF, notshown) were more efficiently infected by rid1 than KOS. In
the absence of nectin-1, it was expected that virus entry into
FED4 would be mediated only by alternate receptors (i.e.
KOS would use HVEM and rid-1 would use nectin-2). To
test this hypothesis, we blocked entry of these viruses into
FED4 and normal fibroblasts with anti-receptor antibodies
(Fig. 4). The entry of HSV-1 KOS into FED4 fibroblasts
was efficiently blocked by an anti-HVEM serum whereas
the anti-nectin-2 serum had no effect (Fig. 4A). On the
contrary, HSV-1 rid1 entry into FED4 cells was totally
blocked by anti-nectin-2 serum but remained unaffected
by the anti-HVEM serum (Fig. 4C). As expected, the potent
neutralizing anti-nectin-1 MAb CK41 (Krummenacher et
al., 2000) had no inhibitory effect on HSV entry into FED4
cells (Fig. 4E). Matching normal fibroblasts and FLF (not
shown) were also susceptible to infection by HSV KOS and
rid1 (Fig. 3B). However, the entry of neither KOS nor rid1
into normal fibroblasts could be efficiently blocked by any
specific anti-receptor antibodies used individually (Figs. 4B,
D, F). This confirms that on normal fibroblasts, these
viruses have redundant possibilities to enter. In addition,
we tested a combination of anti nectin-1 IgG (CK41; 10 Ag/
ml) and anti-HVEM serum (R140; 1/100) to try to prevent
Fig. 4. Blocking HSV entry into fibroblasts. FED4 fibroblasts (A, C) and matched normal fibroblasts (B, D) were preincubated with anti-HVEM (R140), anti-
nectin-2 (R146), or preimmune rabbit serum before inoculation with HSV-1 KOS tk12 (A, B) or mutant HSV-1 rid1 tk12 (C, D). Entry of HSV-1 KOS tk12 and
HSV-1 rid1 tk12 into FED4 (E) and normal fibroblasts (F) in the presence of anti-nectin-1 MAb CK41 is depicted as open symbols. Level of entry was reported
as h-galactosidase activity expressed by the viruses upon infection. Percentage of entry is calculated compared to entry of these viruses at the same MOI
(10 pfu/cell) in the absence of antibody (100%).
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these relatively high concentrations of antibodies, viral entry
was reduced but not completely inhibited (data not shown).
Under these conditions, the possibility remains that an
unknown receptor might still be used on matched NFibro
cells but not on the nectin-1-deficient cell line (FED4).
Despite the genetic defect of the nectin-1 gene, FED4
cells were susceptible to infection by wt and mutant HSV-1rid1, which infected these fibroblasts using either of two
different receptors. We used QFACS to determine the
number of HVEM and nectin-1 molecules on fibroblasts
of various origins (FED4, NFibro, FLF) as well as on a
matched pair of lymphoblastoid cells (LED4 and matched
NLympho) (Fig. 2). As expected, no differences in HVEM
expression between FED4 and other fibroblasts or LED4
and control lymphoblasts were detected (Fig. 2C). Nectin-2
Fig. 5. Efficiency of HVEM and nectin-1 at low cell surface densities. B78
cells were transiently transfected with expression plasmids for HVEM (A)
or nectin-1 (B) and were inoculated with HSV KOS tk12. Level of entry
measured by h-galactosidase activity is reported as a function of the
average number of ABS for CW10 (A) and CK41 (B) on these cells.
Several MOI were tested and a polynomial correlation was calculated for
each of them. The data are representative of three individual experiments.
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be quantified due to the lack of a suitable MAb (data not
shown). LED4 cells exhibited a very low level of anti-
nectin-1 CK41 staining whereas normal matched control
lymphoblasts (NLympho) were comparatively positive for
nectin-1 expression (Fig. 2D). This indicates that the genetic
CLPED1 mutation indeed affects nectin-1 expression on cell
surface. Considering the inherent genetic inability of LED4
and FED4 cells to produce membrane-anchored nectin-1,
the receptor is presumably secreted or degraded. On the
surface of FED4 fibroblasts, the CK41 background signal
was higher, amounting to about 3000 ABS/cell (Fig. 2D). In
addition, CK41 did not detect a significantly higher number
of nectin-1 molecules on matching fibroblasts (NFibro) and
fetal lung fibroblasts (FLF) by QFACS (Fig. 2D). This
suggests that high nonspecific background for CK41 com-
mon on fibroblast cells prevents accurate quantification of
nectin-1. Taken together, the infection data and the quanti-
fication data show that a low amount of nectin-1 (below
quantification level) on normal fibroblasts could efficiently
be used as a receptor for entry.
The relationship between receptor density and efficiency of
infection
Most cell lines express low levels of receptors. More-
over, unquantifiable levels of nectin-1 (by QFACS) were
sufficient to promote HSV entry into normal fibroblasts. We
were interested in learning whether there was a correlation
between the number of receptors on cell surface and
susceptibility of these cells to wild-type HSV infection.
B78 cells were transiently transfected with increasing
amounts of HVEM or nectin-1 plasmid DNA leading to
surface expression of various levels of one or the other
receptor. The transfected cells were infected at different
MOI with HSV KOS tk12 and the level of virus entry was
determined by h-galactosidase activity of the viral reporter
gene. In parallel to the entry assay, the number of receptors
on the surface of each cell population was determined by
QFACS as described above. We observed a direct relation-
ship between virus entry and the average number of recep-
tors per cell regardless of MOI (Fig. 5). This correlation was
observed even when very low levels of receptors were
expressed, extending down to about 1500 HVEM or 500
nectin-1 molecules per transfected B78 cell on average.
These numbers are at the low limit of sensitivity of QFACS
for these receptors on transiently transfected cells. We did
not observe a threshold effect for any of the receptors.
Therefore, we conclude that the efficiency of virus entry is
directly related to the numbers of receptors on cells at least
at low receptor densities. It should be noted that the range of
receptor numbers in this experiment is the same as that
found for several permissive cell lines. Moreover, at high
MOI, a positive signal for virus entry was detected even
when receptor numbers were below what could be deter-
mined by QFACS.In addition, this approach enabled us to directly compare
the efficiency of HVEM and nectin-1 at mediating HSV
entry. Interestingly, for any given number of receptors (i.e.
2500/cell), the signal for HSV entry was consistently higher
for nectin-1 than for HVEM at each MOI tested (note the
scale difference between Figs. 5A and B). Therefore, it
appears that under these conditions, each nectin-1 molecule
allows for more efficient HSV entry than HVEM.Discussion
Many viruses are able to use several receptors or co-
receptors during the process of entry into cells. They can be
from the same structural family such as the chemokine
receptors for HIV (Baribaud and Doms, 2001) or they can
be unrelated as for measles virus. In the latter case, differ-
ences in usage were found between laboratory strains and
primary isolates (Dorig et al., 1993; Erlenhofer et al., 2002;
Tatsuo et al., 2000). For HSV, two main types of protein
receptor allow for HSV entry: HVEM which belongs to the
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family of Ig-like proteins (Geraghty et al., 1998; Montgom-
ery et al., 1996). HSVenvelope gD is the common ligand for
each receptor and the interaction between gD with one or the
other receptor is absolutely required for HSV entry to
proceed (Krummenacher et al., 1998; Whitbeck et al., 1997).
Receptor tropism of HSV primary isolates
Although wt HSV can use both HVEM and nectin-1 in
vitro, it is not clear whether both receptors are actually used
and required during the infectious cycle in vivo which
involves several cell types. By testing several primary
HSV isolates, we found that all of them were able to use
HVEM as well as nectin-1. No isolate displayed the tropism
of the rid1 strain unable to use HVEM although this
phenotype is viable in cell culture. One exception was the
ANG virus. This particular virus originated as a genital
isolate and was serially passaged in cell culture multiple
times (Munk and Ludwig, 1972). It is not known if the
mutations in ANG gD associated with receptor usage were
present in the original isolate or were acquired during
culture in laboratory cell lines. Because this phenotype is
not commonly seen in clinical isolates, our findings suggest
that both HVEM and nectin-1 play a role in vivo. Each
receptor might promote entry into different cell types
required at different stages for in vivo spread of HSV.
However, based on expression patterns of each receptor,
one can also suspect that the interaction with HVEM might
play a role in immune evasion in addition to or instead of
acting in cell and tissue tropism during HSV spread (La et
al., 2002; Raftery et al., 1999). Among the isolates tested
here, HSV obtained from genital lesions, mainly type 2,
used nectin-2 more efficiently than the type 1 oral isolates.
This is consistent with the observation that nectin-2 en-
hanced entry of HSV-2 laboratory strains into CHO cells
(Warner et al., 1998). The HSV-2 laboratory strain 333 also
entered CHO cells more efficiently than HSV-1 strains when
used at high MOI (>10 pfu/cell)(Montgomery et al., 1996).
In a comparative assay performed under the conditions
described for Fig. 1 (MOI = 0.5–1 pfu/cell), HSV-2 strains
333 and 186 showed similar entry levels on CHO IEh8 cells
(data not shown). Both strains entered these cells more
efficiently when tested at a higher MOI (4 pfu/cell).
Regardless of serotype, neonatal isolates, which spread
more extensively in the host, did not show aberrant receptor
usage. Severity of neonatal infections might be due to other
virulence factors and to the immature immune system of the
newborn (Whitley, 2001). Interestingly, several viruses from
encephalitic patients were more efficient at using nectin-2 as
well as a putative receptor on CHO cells. So far, we have
not correlated that aspect with specificity of the gD gene
from CNS isolates. Although our sampling covered isolates
from many different sources, it remained limited in number.
Extending this study to a larger collection of clinical
samples will be required to confirm the trends we observedin the present study. In addition, our data do not rule out the
possibility that a specific subset of isolates could use an
unknown receptor, possibly in the growing family of nectins
and nectin-like molecules.
Receptor usage
Nectin-1 is expressed in a wide range of tissues and cells.
Primary targets for HSV such as sensory neurons or
epithelial cells are known to express detectable levels of
nectin-1 (Mata et al., 2001). Moreover, nectin-1 rather than
HVEM is used by HSV to enter fresh primary neurons in
culture (Richart et al., 2003). Distribution of HVEM,
although more restricted than nectin-1, is still fairly broad.
We found that the amount of HVEM and nectin-1 varied
significantly from cell line to cell line, but both receptors
were usually expressed by the same cells. The average
numbers that we obtained were in the range of what has
been found for other viral receptors on susceptible cells
(Reynes et al., 2000, 2001). Variation was observed on
similar cell types such as neuroblastomas, whereas different
types of fibroblasts seemed to express extremely low levels
of nectin-1 (Hung et al., 2002). The rate of HSV-1 entry is
similar in SY5Y and Vero cells (Handler, 1996; Rosenthal et
al., 1988) and is in the same range as that observed for other
epidermal cells (Rosenthal et al., 1985). Although receptor
numbers influence susceptibility to infection (see below and
Fig. 5), availability of such receptors (Yoon and Spear,
2002) as well as other cellular factors might affect the rate of
viral entry.
In addition, we found that although normal fibroblasts
expressed nectin-1 at levels below QFACS quantification,
this receptor could be used for HSV entry. Previous experi-
ments showed that a mutant virus containing 500-fold less
gD was able to infect HaCat cells that express a high level of
receptor but were unable to infect Vero cells (Huber et al.,
2001). By analogy, one can assume that a high density of
gD on virion compensates for low numbers of receptors on
various cells. Interestingly, in HIV infection, lower levels of
CCR5 on cell surface were correlated with lower amounts of
virus production and slower progression to AIDS (Reynes et
al., 2000, 2001). It is not yet known how much the levels of
expression of nectin-1 and HVEM vary between individuals
and whether that variability plays a role in severity of HSV
pathogenesis.
Because both receptors were co-expressed on most cells
that we tested, it is difficult to determine if one is globally
preferred over the other. One approach would be to specif-
ically block one receptor with antibodies and then determine
if the other can be used. However, in this situation, the
results might be skewed because HSV might use the
alternate receptor, although it was not the case when both
were available. As a different approach, we decided to
compare HVEM and nectin-1 efficacy when expressed
independently at low levels. For both receptors, there was
a direct correlation between receptor number and levels of
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markably effective even at very low receptor density.
However, HVEM required a higher density than nectin-1
to permit the same level of virus entry. We showed previ-
ously that soluble forms of both receptors bound to gD with
the same affinity but to different sites (Krummenacher et al.,
1998; Nicola et al., 1998). Therefore, the difference in
efficiency is not explained by differences in affinity. Factors
other than direct binding can affect receptor efficacy such as
receptor accessibility (Yoon and Spear, 2002), post-receptor-
binding events leading to membrane fusion, or post-entry
connections (e.g. association of receptor with the right
cellular components such as cytoskeleton or signal trans-
mission factors). In addition, we do not exclude that
receptors might be present in various conformations on
the cell surface that might not be accounted for by the
antibodies we used, as it was shown for other molecules
such as chemokine receptors (Baribaud and Doms, 2001;
Lee et al., 1999a).
In summary, we found that amounts of HVEM or
nectin-1 molecules, even below the level of reliable
quantification, were sufficient to permit entry. Our data
support the conclusion that both HVEM and nectin-1 are
needed for HSV to complete its life cycle in vivo. The
isolation of HSV strains using a single receptor, the
definition of animal models at the receptor level, and the
study of human polymorphisms will provide approaches to
extend our data and help our understanding of the exact
roles of HVEM and nectin-1 during HSV pathogenesis and
spread in vivo.Materials and methods
Virus strains and isolates
HSV-1 KOS tk12 and HSV-1 rid1 tk12 expressing the
lacZ gene under the ICP4 promoter (Montgomery et al.,
1996) as well as all HSV laboratory strains were grown and
titered on Vero cells and purified as described (Handler et
al., 1996). Primary isolates obtained through the kindness of
various laboratories (Table 1) were amplified once on Vero
cells to produce working stocks. Infected cells were lysed by
two cycles of freezing and thawing in culture medium. The
lysate was cleared by low speed centrifugation (2500  g).
The crude virus stock supernatant was titered on Vero cells
as described (Handler et al., 1996).
Cells
Chinese hamster ovary cells (CHO) cells expressing
the lacZ gene under the HSV ICP4 promoter (CHO-IEh8)
were grown in HAM’s F-12 medium supplemented with
10% fetal calf serum (FCS) and 150 Ag/ml puromycin
(Montgomery et al., 1996; Warner et al., 1998). M1A,
M2A, and M3A cells were derived from CHO-IEh8 andexpress constitutively human HVEM, nectin-2, or nectin-
1, respectively, under the control of a cytomegalovirus
early promoter. M1A, M2A, and M3A cells were grown
in HAM’s F-12 medium supplemented with 10% FCS,
150 Ag/ml puromycin, and 250 Ag/ml G418 (Krumme-
nacher et al., 1998).
Murine melanoma B78H1 cells (Graf et al., 1984), Vero,
and Hela cells were grown in DMEM supplemented with 5%
FCS. Human neuroblastoma cells IMR5 and SY5Y, as well
as A431 cells and 293T cells were grown in DMEM
supplemented with 10% FCS. Cell lines derived from
B78H1 cells were grown in DMEM supplemented with
5% FCS and 500 Ag/ml G418. These are: A10 and B78-A
cells isolated independently and expressing human HVEM
(Connolly et al., 2003; Miller et al., 2001; Milne et al., 2003),
C10 cells expressing human nectin-1 (Krummenacher et al.,
2002; Miller et al., 2001), CXG10 and CG23 expressing
nectin-1-GFP fusion proteins (Krummenacher et al., 2003),
and as a control B78H1-control16 (abbreviated here as B78)
transfected with empty pCDNA3.1 vector (Krummenacher
et al., 2002; Miller et al., 2001).
Human fibroblasts FED4 (NIGMS Human Genetic
Mutant Cell Repository No. GM14818) from a CLPED1
patient and matched control normal fibroblasts NFibro
(repository No.GM03652F) and fetal lung fibroblasts
(FLF) (a gift from Dr. J. Rosenbloom, UPENN) were
grown in alpha MEM supplemented with 15% FCS and
2 mM glutamine. Human lymphoblasts LED4 (NIGMS
Human Genetic Mutant Cell Repository No.GM14817)
from a CLPED1 patient and matched normal lympho-
blasts (NLympho, repository No.GM00130) were grown
in RPMI medium supplemented with 15% heat-inacti-
vated FCS and 2 mM glutamine.
Entry assay
Cells were grown to confluence in their respective me-
dium in a 96-well plate. Viral stocks were diluted in medium
and 100 Al per well was added to chilled cells for 1 h at 4 jC
(this step was omitted with transiently transfected B78 cells)
and then incubated at 37 jC for 5–6 h. Cells were then
lysed by adding 1 volume of medium containing 1% NP40
(final concentration 0.5%). Then, 50 Al of cell lysate was
tested for h-galactosidase activity using chlorophenol-red-
h-D-galactopyranoside as a substrate. The level of entry was
monitored by reading the absorbance at 595 nm for 50 min
to record the enzymatic activity, expressed as the change in
optical density per hour (DOD/h).
Blocking assay
The entry assay described above was modified by pre-
incubating cells at 4 jC for 1 h with anti-receptor antibodies
diluted in culture medium (50 Al/well). An equal volume of
purified KOS tk12 or rid1 tk12 virus (Warner et al., 1998)
diluted in culture medium (multiplicity of infection of 10
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h. Beta-galactosidase activity was used to monitor HSV
entry. Blocking activity of anti-receptor antibodies is
expressed as the percentage of virus entry into cells under
test conditions compared to viral entry in the absence of
antibodies (100%).
Quantification of HVEM and nectin-1 on cell lines
Quantitative fluorescence activated cell sorting (QFACS)
was performed by converting the mean channel fluores-
cence of stained cell populations into antibody binding sites
(ABS) using a set of standardized microbeads (Quantum
simply cellular microbead kit, Sigma). This set consists of a
mixture of different microbeads of uniform size, coated
with various amounts of goat anti-mouse Ig. Each popula-
tion of beads binds a different but defined amount of mouse
Ig and as a control one population does not bind mouse Ig
(Baribaud et al., 2002; Lee et al., 1999b). Monoclonal
antibodies CW10, anti-HVEM (Bender et al., 2003), and
CK41, anti-nectin-1 (Krummenacher et al., 2000) were
directly conjugated with phycoerythrin (PE) while anti-
nectin-1 MAb CK6 (Krummenacher et al., 2000) was
coupled to allophycocyanin (APC) at Molecular Probes,
Inc, Eugene, OR. CW10-PE and CK41-PE Ig were used at
concentrations able to saturate cell surface of highly posi-
tive cells (A10 and C10, respectively), that is, 20 and 5 Ag/
ml, respectively. Anti-nectin-1 CK6-APC (Krummenacher
et al., 2000) had to be used below saturation level (20 Ag/
ml) and is shown for qualitative comparison. Cells were
detached with 0.02% di-sodium EDTA (w/v) in PBS
(Versene; Gibco-BRL) and resuspended in PBS containing
3% FCS, 0.01% sodium azide (PBS-FCS). Antibodies were
diluted in 50 Al PBS-FCS and added to approximately 3 
105 cells and incubated on ice for 1 h. Microbeads (15 Al)
were processed identically as the samples being analyzed.
Samples were washed with PBS-FCS and fixed with 3%
paraformaldehyde in PBS-FCS. After FACS analysis, the
mean fluorescence intensity (MFI) of each microbead
population was correlated with its Ig binding capacity.
The linear regression obtained was used to convert the
MFI of the antigen analyzed on the cell samples into
antibody binding sites (ABS) per cell.
Correlation of number of antibody binding sites with
susceptibility to HSV entry
B78H1 cells (Krummenacher et al., 2002; Miller et al.,
2001), which do not naturally express HSV receptors, were
transfected with various amounts of expression plasmids
for HVEM or nectin-1. Plasmid pCK451 contains the
human nectin-1 ORF from plasmid pBG38 (Geraghty et
al., 1998) inserted in sites HindIII and BamH1 of
pCDNA3.1 (Krummenacher et al., 2003). In this construct,
the vector-encoded stop codon is used. Plasmid pSC386
expresses human HVEM in pCDNA3.1 background (Con-nolly et al., 2002). Subconfluent cells in six-well plates
were transfected with 300, 100, 30, 10, 3, or 1 ng of
pCK451 or pSC386 per well. A control without expression
plasmid was also used. Plasmid pUC19 was used as carrier
DNA to bring the total DNA amount to 3 Ag/well. DNA
was mixed with GenePORTER (Gene therapy Systems,
Inc., San Diego, CA) (15 Al/well) in 1 ml/well serum-free
DMEM for 30 min at RT. The mixture was added to cells
for 3.5 h at 37 jC, then 1 ml of DMEM supplemented
with 20% FCS and 2 antibiotics was added for an
overnight incubation at 37 jC.
At that stage, cells were detached with trypsin and the
required number was seeded on 96-well plates for an
entry assay, and the rest was replated and cultured
overnight. Forty hours post transfection, cells in a 96-
well plate were infected with HSV-KOStk12 at various
MOI for an entry assay. The remaining cells were
detached with Versene and subjected to a quantitative
FACS analysis as described above. Monoclonal antibodies
CW10-PE and CK41-PE were used to detect HVEM and
nectin-1, respectively.Acknowledgments
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